Vertaling van "regulatory submissions have also been " (Nederlands → Frans) :

Regulatory submissions have also been completed in Japan and China.
Des demandes d’autorisation ont été également déposées au Japon et en Chine.

Submission for US regulatory approval, which had been anticipated in 2009, is now expected in 2012.
Attendu pour 2009, le dépôt d’une demande d’autorisation aux Etats-Unis est maintenant prévu en 2012.

MenB, in development as a vaccine to protect against the B serogroup of meningococcal meningitis, is in Phase III studies in Europe, where patient enrollment has been completed and a regulatory submission remains on track for 2010.
MenB, en développement en tant que vaccin pour protéger contre le sérogroupe B de la méningite à méningocoque, et en études de phase II en Europe.

Regulatory submissions also are planned this year in Japan and China.
Des demandes devraient être déposées cette année au Japon et en Chine.

Regulatory submissions are also planned for 2010 in Japan and China.
Des demandes devraient être déposées en 2010 au Japon et en Chine.

This information has also been submitted to European regulatory authorities.
Cette information a également été remise aux autorités réglementaires de l’Union européenne.

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

More than 30 positive regulatory decisions have been achieved to date in 2009 in the US, European Union and Japan.
Plus de trente décisions réglementaires favorables ont été accordées à ce jour en 2009 aux Etats-Unis, dans l’Union européenne et au Japon.

With no systematic records available of the attempted suicides that have been seen by a doctor, the data concerning attempted suicides are also often collected by means of general population surveys.
En l’absence d’enregistrement systématique des tentatives de suicide aboutissant auprès d’un médecin, les données sur les tentatives de suicide sont souvent recueillies également par le biais d’enquête en population générale.

Gender-related differences have also been observed in the form the depression can take in so far as men seek less medical help than women do (who, as a result of their role as a mother and a cultural “predisposition” to express what they feel, are more likely to call on doctors); depression in males is therefore more difficult to detect.
On a également pu observer des différences dans la forme que peut revêtir la dépression en fonction du sexe dans la mesure où les hommes sollicitent moins l’aide du monde médical que les femmes (plus enclines à faire appel aux médecins, par leur rôle de mère, et une « prédisposition » culturelle à formuler ce qu’elles ressentent); la dépression chez le sexe masculin est donc plus difficile à déceler.